StockWatch
·

UPL Limited

BSE: 512070

P/L Snapshot

Q1 FY27 · standalone

vs Q4 FY26·vs Q1 FY26
Revenue
1.5K
-5.2%-13.3%
Expenditure
1.4K
+25.0%-13.7%
Net Profit
89.00
-75.2%-27.0%
OPM %
3.36%
-5.49pp-2.24pp

Shareholding

Pattern breakdown

P/L Trends

(in crores)

RevenueExpenditureNet Profit
0.00606.481.2K1.8K2.4KQ2 FY25Q3 FY25Q4 FY25Q1 FY26Q2 FY26Q3 FY26Q4 FY26Q1 FY27
Price Chart
Latest News
Board Meeting3 Aug, 3:18 pm

UPL Q1: consol loss narrows to ₹73 Cr, revenue +10% YoY as deleveraging cuts finance cost

UPL's consolidated Q1 FY27 revenue rose 10.5% YoY to ₹10,181 Cr (from ₹9,216 Cr), but the Group still posted a net loss of ₹73 Cr for the period — roughly half the ₹176 Cr loss a year ago. The composition matters: profit attributable to owners of the parent swung positive to ₹10 Cr from an ₹88 Cr loss, while the ₹83 Cr loss now sits with non-controlling interests. Basic EPS was ₹0.12. Sequentially revenue fell 44.5% from ₹18,335 Cr, but that is agrochemical seasonality (the Jan–Mar Rabi quarter is the year's strongest, Apr–Jun the weakest), not a slowdown; QoQ should not be read as the story here. The swing to a narrower loss is led by deleveraging: finance costs dropped to ₹852 Cr from ₹1,007 Cr YoY (−15%), the clearest evidence the debt-reduction campaign we flagged pre-result is feeding through. Crop protection revenue grew 5.7% to ₹7,659 Cr and Seeds & Post-harvest 24.6% to ₹1,750 Cr; total segment EBIT was ₹1,110 Cr vs ₹985 Cr. One caveat on the loss-narrowing: other income carries a one-off ₹55 Cr Bombay High Court insurance arbitral award — strip it (the year-ago period had no equivalent) and the underlying loss is closer to ₹128 Cr, so the ~58% reported loss-narrowing overstates; the adjusted narrowing is nearer ~27%. Net margin improved (−0.7% vs −1.9% YoY) while operating margin held around 16%. Against the bar we set in our preview — ₹11,700–12,100 Cr revenue and +14–18% EBITDA — the print missed: revenue landed 13–16% below and EBITDA was broadly flat, so management's own 14–18% EBITDA guidance was not met this quarter, though the 10–14% revenue-growth guide was met at its low end. Street had built the FY27 thesis on ~72% consolidated profit growth; a still-loss-making Q1 is a soft (if seasonally weakest) start. On the corporate front, the Composite Scheme of Arrangement (UPL SAS amalgamation, appointed date April 1, 2026) received BSE/NSE observation letters on July 29 but has no P&L effect yet, pending NCLT and shareholder approvals; the $1 Sustainable Tech acquisition and the Bioplanta stake divestment are immaterial. Standalone, revenue fell 15.8% YoY to ₹1,397 Cr with PAT of ₹89 Cr (vs ₹122 Cr) — the standalone entity is a small slice of the Group, so the consolidated picture governs.

3 Aug 2026, 03:18 pm

Corporate Events

Board MeetingUPL
2026
6Aug

Board Meeting

The 42nd Annual General Meeting ("AGM") of UPL Limited has b…

BSE Filing ↗
Board MeetingUPL
2026
3Aug

Board Meeting

The meeting of the Board of Directors is scheduled to consid…

BSE Filing ↗
DividendUPL
2026
17Jul

₹6 / share

BSE Filing ↗
DividendUPL
2025
11Jul

₹300 / share

BSE Filing ↗
Board MeetingUPL
2024
11Nov

Board Meeting

consider and approve and take on record the unaudited standa…

BSE Filing ↗
Board MeetingUPL
2024
13May

Board Meeting

Consider and approve the audited standalone and consolidated…

BSE Filing ↗
Board MeetingUPL
2024
2Feb

Board Meeting

Consider and approve unaudited standalone and consolidated f…

BSE Filing ↗
Board MeetingUPL
2023
22Dec

Board Meeting

Proposal of fund raising by issue of equity shares

BSE Filing ↗